P, F., RL, B., C, L., B, G., B, B., AM, M., . . . H, G. (2016). Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring-The TADE Study. Clinical cancer research : an official journal of the American Association for Cancer Research, 22(13), 3164. https://doi.org/10.1158/1078-0432.CCR-15-1470
Chicago Style (17th ed.) CitationP, Fox, et al. "Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring-The TADE Study." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 22, no. 13 (2016): 3164. https://doi.org/10.1158/1078-0432.CCR-15-1470.
MLA (9th ed.) CitationP, Fox, et al. "Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring-The TADE Study." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 22, no. 13, 2016, p. 3164, https://doi.org/10.1158/1078-0432.CCR-15-1470.